A Szegedi Tudományegyetem – Universitas Scientiarum Szegediensis / University of Szeged – Magyarországon, Szeged városában működő, közfeladatot ellátó, közérdekű vagyonkezelő alapítvány által fenntartott felsőoktatási intézmény.

During the past decade, Szegedi Tudományegyetem conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 11 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szegedi Tudományegyetem" #1 sponsor was "Janssen Research & Development, LLC" with 10 trials, followed by "Shire" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Allergan" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szegedi Tudományegyetem" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Szegedi Tudományegyetem" are "Psoriasis" (3 trials), "ADHD" (2 trials), "Crohn Disease" (2 trials), "Diabetes Mellitus" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Szegedi Tudományegyetem" in a lesser frequency.

Most popular intervention types in "Szegedi Tudományegyetem" are "Drug" (28 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Guselkumab" (3 trials), "BMS-986165" (2 trials), "Methylphenidate Hydrochloride" (2 trials) and "Niraparib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Szegedi Tudományegyetem" are 26 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Szegedi Tudományegyetem". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Szegedi Tudományegyetem, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Szegedi Tudományegyetem, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Szegedi Tudományegyetem has several departments that took part in Clinical trials: "Department of Anaesthesiology and Intensive Therapy" - 8 trials, "Szegedi Tudományegyetem ÁOK; Department of Ophtalmology" - 8 trials, "University of Szeged Department of dermatology and allergology" - 5 trials, "Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ; Neurológiai Klinika" - 4 trials, "SZTE AOK Borgyogyaszati es Allergologiai Klinika" - 4 trials, "Szegedi Tudományegyetem ÁOK Szent-Györgyi Albert Klinikai Központ II.sz. Belgyógyászati Klinika és Kardiológiai Központ" - 2 trials, "University of Szeged, Department of Anesthesiology and Intensive Therapy" - 2 trials, "Department of Traumatology, University of Szeged" - 2 trials, "SZTE Szentgyorgyi Albert Klinikai Kozpont/Borgyogyaszati es Allergologiai Klinika" - 2 trials